Minireviews
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jan 7, 2016; 22(1): 427-434
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.427
Table 2 Risk factors for non-skin solid tumors after liver transplantation from multivariate analyses
Ref.Risk factorAssociated cancerSIR, HR, RR, or OR (95%CI)
Viral infectionBaccarani et al[8]HPV exposureCervicalSIR = 30.7 (6.3-90)
Collett et al[9]AnalSIR = 3.3 (0.4-12)
Baccarani et al[8]HHV8 exposureKaposi’s sarcomaSIR = 144 (53-313)
Maggi et al[17]SIR = 128 (51-263)
Demographic dataHerrero et al[22]Recipient’s ageAll non-skin tumorsHR = 1.90 (1.32-2.73)
Watt et al[23]All non-skin solid tumorsHR = 1.33 (1.05-1.66)
Herrero et al[34]Smoking-related tumorsHR = 1.09 (1.03-1.15)
Indication for LTWatt et al[23]Alcohol cirrhosisAll non-skin solid tumorsHR = 2.14 (1.22-3.73)
Primary sclerosis cholangitisAll non-skin solid tumorsHR = 2.62 (1.50-4.56)
LifestyleBenlloch et al[53]Alcohol consumptionAll non-skin tumorsRR = 3 (1.5-5.8)
Herrero et al[22]HR = 2.87 (1.15-7.19)
Herrero et al[22]Tobacco consumptionAll non-skin tumorsHR = 3.07 (1.32-7.16)
Watt et al[23]All non-skin solid tumorsHR = 1.72 (1.06-2.79)
Carenco et al[13]OR = 5.5 (2.5-12)
Herrero et al[34]Smoking-related tumorsHR = 19.17 (4.17-88.10)
Carenco et al[13]OR = 14.7 (1.8-119)
Carenco et al[13]ObesityAll non-skin solid tumorsOR = 2.2 (1.1-4.3)
ImmunosuppressionCarenco et al[49]Mean tacrolimus TC during first year post-LTAll non-skin solid tumorsOR = 2.01 (1.57-2.59)